Gene-diet interactions on plasma lipid levels in the Inuit population

British Journal of Nutrition

Volumn 109, Issue 5, 2013, Pages 953-961

  Rudkowska, Iwona ^a,b   Dewailly, Eric ^b   Hegele, Robert A ^c   Boiteau, Véronique ^b   Dubé Linteau, Ariane ^b   Abdous, Belkacem ^b   Giguere, Yves ^b   Chateau Degat, Marie Ludivine ^b   Vohl, Marie Claude ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

HDL cholesterol; LDL cholesterol; Polymorphisms; Saturated fat; TAG; Total cholesterol; Total fat

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA EXTRACTION; ESKIMO; FAT INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; DIET; DIET RECORDS; DIETARY FATS; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HEALTH SURVEYS; HUMANS; INUITS; LIPID METABOLISM; LIPIDS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84874704279     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512002231     Document Type: Article

References (43)

1. Chateau-Degat ML, Dewailly E, Louchini R, et al. (2010) Cardiovascular burden and related risk factors among Nunavik (Quebec) Inuit: insights from baseline findings in the circumpolar Inuit health in transition cohort study. Can J Cardiol 26, 190-196.
2. Counil E, Julien P, Lamarche B, et al. (2009) Association between trans-fatty acids in erythrocytes and pro-Atherogenic lipid profiles among Canadian Inuit of Nunavik: possible influences of sex and age. Br J Nutr 102, 766-776.
3. Chateau-Degat ML, Dewailly E, Noel M, et al. (2010) Hypertension among the Inuit from Nunavik: should we expect an increase because of obesity? Int J Circumpolar Health 69, 361-372.
4. Lewington S, Whitlock G, Clarke R, et al. (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-Analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370, 1829-1839.
5. Bansal S, Buring JE, Rifai N, et al. (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298, 309-316.
6. Rudkowska I & Vohl MC (2010) Interaction between diets, polymorphisms and plasma lipids levels. Clin Lipidol 5, 421-438.
7. Hegele RA, Young TK & Connelly PW (1997) Are Canadian Inuit at increased genetic risk for coronary heart disease? J Mol Med 75, 364-370.
8. de Maat MP, Bladbjerg EM, Johansen LG, et al. (1999) DNApolymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit-is there a relation with the low risk of cardiovascular disease in the Inuit? Thromb Haemost 81, 547-552.
9. Kuczmarski RJ & Flegal KM (2000) Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 72, 1074-1081.
10. Santé-Québec A (1994) A Health Profile of the Inuit: Report of the Santé-Québec Health Survey among the Inuit of Nunavik, 1992, Montréal.
11. McNamara JR & Schaefer EJ (1987) Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 166, 1-8.
12. Burstein M & Samaille J (1960) On a rapid determination of the cholesterol bound to the serum alpha-And beta-lipoproteins. Clin Chim Acta 5, 609.
13. Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
14. Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15, 45-52.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486-2497.
16. Kathiresan S, Melander O, Guiducci C, et al. (2008) Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40, 189-197.
17. Ordovas JM, Lopez-Miranda J, Mata P, et al. (1995) Gene-diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis 118, S11-S27.
18. Lopez-Miranda J, Marin C, Castro P, et al. (2000) The effect of apolipoprotein B xbaI polymorphism on plasma lipid response to dietary fat. Eur J Clin Invest 30, 678-684.
19. Friedlander Y, Berry EM, Eisenberg S, et al. (1995) Plasma lipids and lipoproteins response to a dietary challenge: analysis of four candidate genes. Clin Genet 47, 1-12.
20. Talmud PJ, Boerwinkle E, Xu CF, et al. (1992) Dietary intake and gene variation influence the response of plasma lipids to dietary intervention. Genet Epidemiol 9, 249-260.
21. Rantala M, Rantala TT, Savolainen MJ, et al. (2000) Apolipoprotein B gene polymorphisms and serum lipids: meta-Analysis of the role of genetic variation in responsiveness to diet. Am J Clin Nutr 71, 713-724.
22. Lopez-Miranda J, Ordovas JM, Ostos MA, et al. (1997) Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arterioscler Thromb Vasc Biol 17, 1765-1773.
23. Mata P, Lopez-Miranda J, Pocovi M, et al. (1998) Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation. Atherosclerosis 137, 367-376.
24. Ordovas JM, Corella D, Cupples LA, et al. (2002) Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sexspecific manner: the Framingham Study. Am J Clin Nutr 75, 38-46.
25. Angotti E, Mele E, Costanzo F, et al. (1994) A polymorphism (G ! A transition) in the 278 position of the apolipoprotein A-I promoter increases transcription efficiency. J Biol Chem 269, 17371-17374.
26. Moreno JA, Perez-Jimenez F, Marin C, et al. (2004) Apolipoprotein E gene promoter 2219G ! T polymorphism increases LDL-cholesterol concentrations and susceptibility to oxidation in response to a diet rich in saturated fat. Am J Clin Nutr 80, 1404-1409.
27. Fan YM, Raitakari OT, Kahonen M, et al. (2009) Hepatic lipase promoter C-480T polymorphism is associated with serum lipids levels, but not subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study. Clin Genet 76, 46-53.
28. Ordovas JM, Corella D, Demissie S, et al. (2002) Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 106, 2315-2321.
29. Zhang C, Lopez-Ridaura R, Rimm EB, et al. (2005) Interactions between the 2514C ! T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men. Am J Clin Nutr 81, 1429-1435.
30. Zhang C, Lopez-Ridaura R, Rimm EB, et al. (2006) Genetic variation in the hepatic lipase gene and the risk of coronary heart disease among US diabetic men: potential interaction with obesity. Diabetologia 49, 1552-1559.
31. Zafarmand MH, van der Schouw YT, Grobbee DE, et al. (2008) The M235T polymorphism in the AGT gene and CHD risk: evidence of a Hardy-Weinberg equilibrium violation and publication bias in a meta-Analysis. PLoS One 3, e2533.
32. Shioji K, Mannami T, Kokubo Y, et al. (2004) An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese. J Hum Genet 49, 433-439.
33. Yamada Y, Matsuo H, Warita S, et al. (2007) Prediction of genetic risk for dyslipidemia. Genomics 90, 551-558.
34. Bego T, Dujic T, Mlinar B, et al. (2011) Association of PPARG and LPIN1 gene polymorphisms with metabolic syndrome and type 2 diabetes. Med Glas Ljek komore Zenicko-doboj kantona 8, 76-83.
35. Kraja AT, Province MA, Straka RJ, et al. (2010) Fenofibrate and metabolic syndrome. Endocr Metab Immune Disord Drug Targets 10, 138-148.
36. Russo GT, Meigs JB, Cupples LA, et al. (2001) Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis 158, 173-181.
37. Lopez-Miranda J, Ordovas JM & Marin C (1994) The SstI polymorphic site at the apolipoprotein C-III gene predicts plasma low-density lipoprotein response to changes in dietary fat in young men. Circulation 90, I.
38. Darabi M, Abolfathi AA, Noori M, et al. (2009) Cholesteryl ester transfer protein I405V polymorphism influences apolipoprotein A-I response to a change in dietary fatty acid composition. Horm Metab Res 41, 554-558.
39. Sreeja L, Syamala V, Hariharan S, et al. (2005) Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50, 618-627.
40. Delgado-Lista J, Perez-Martinez P, Perez-Jimenez F, et al. (2010) ABCA1 gene variants regulate postprandial lipid metabolism in healthy men. Arterioscler Thromb Vasc Biol 30, 1051-1057.
41. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, et al. (2008) Genetic variation in ABCA1 predicts ischemic heart disease in the general population. Arterioscler Thromb Vasc Biol 28, 180-186.
42. Kolovou V, Kolovou G, Marvaki A, et al. (2011) ATP-binding cassette transporter A1 gene polymorphisms and serum lipid levels in young Greek nurses. Lipids Health Dis 10, 56.
43. Liao YC, Lin HF, Rundek T, et al. (2008) Multiple genetic determinants of plasma lipid levels in Caribbean Hispanics. Clin Biochem 41, 306-312.